BRIACELL THERAPEUTICS CORP. Class of Warrant or Right, Outstanding
BRIACELL THERAPEUTICS CORP. (BCTX) had Class of Warrant or Right, Outstanding of 300 shares as of 2023-04-30, per its 10-Q filed 2023-06-14.
Discontinued › Notes › Other Liabilities
us-gaap:ClassOfWarrantOrRightOutstanding · last filed 2023-06-14
- 2023-04-30: Class of Warrant or Right, Outstanding 300.00 shares.
| Period end | Class of Warrant or Right, Outstanding |
|---|---|
| 2023-04-30 | 300.00 shares 10-Q · filed 2023-06-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PMGC Holdings Inc. (ELAB) | United States | $0.037B | |
| Seres Therapeutics, Inc. (MCRB) | United States | $0.036B | -3.45 |
| FILANA THERAPEUTICS, INC. (FLNA) | United States | $0.038B | -1.05 |
| Actinium Pharmaceuticals, Inc. (ATNM) | United States | $0.038B | 2.73 |
| MIRA PHARMACEUTICALS, INC. (MIRA) | United States | $0.036B | -4.30 |
| Celularity Inc (CELU) | United States | $0.038B | -0.34 |
| CervoMed Inc. (CRVO) | United States | $0.038B | -1.39 |
| Edesa Biotech, Inc. (EDSA) | Canada | $0.039B | |
| ROCKWELL MEDICAL, INC. (RMTI) | United States | $0.035B | |
| Karyopharm Therapeutics Inc. (KPTI) | United States | $0.039B | -0.98 |